← Return to Anyone here after ADT undergone TRT

Discussion
ava11 avatar

Anyone here after ADT undergone TRT

Prostate Cancer | Last Active: Aug 13, 2025 | Replies (21)

Comment receiving replies
Profile picture for kenk1962 @kenk1962

Thank you Rotate for the reply regarding total testosterone (TT) and PSA levels.

I agree with your trepidation to participate in a Gleason 9 clinical trial without using ADT. Gosh...Gleason 9 is a serious and scary classification. Gleason 9 treatment typically uses all available tools to fight the cancer. As much as I hate the awful side effects of ADT, I acknowledge ADT has been viewed as necessary to fight anything more aggressive than Gleason 3+4=7 cancer.

When you enrolled in your clinical trial, do you recall the reason(s) the trial's director or leader provided for why their team believed the "no ADT needed for Gleason 9" trial had a decent likelihood of success? For example:
- Does the trial use some sort of improved technology whereby ADT is thought to no longer be needed?
- Does the trial use something else (e.g., maybe repurposed drugs, maybe higher radiation doses, perhaps a different way to administer drugs or radiation) for which it believes enduring ADT is not needed?

I suspect there is an underlying reason to support the trial's "no ADT needed for Gleason 9" hypothesis. I'm not smart enough to speculate on what that might be, but I bet it can be found. Seems implausible for an institution or medical equipment vendor to invest their money in a trial without a reason to believe a better outcome can be achieved.

I'd recommend investigating/seeking the reason supporting the trial's purpose. Then I'd run the reason through some different A.I. programs. For what it's worth, I'm a fan of Perplexity.AI Pro (costs $20 for a monthly subscription) which I use frequently. At a minimum the A.I. programs will give you some independent feedback and references to the scientific articles used in the A.I.'s analysis.

Jump to this post


Replies to "Thank you Rotate for the reply regarding total testosterone (TT) and PSA levels. I agree with..."

The trial used more complex decision making than normal - especially DECIPHER.

The rule for no ADT is for only one risk marker of:

Gleason, PSA, T category, DECIPHER score.

Also, some urologists have been doing less or no ADT.

The standard of care in the trial is normal, except for the ADT (for the low risk group), or less ADT for the intermediate risk. Not sure about the High Risk group because I don't know the non-trial standard of care.

And yes, it is scary. I did a lot of analysis (with the help of AIm BTW) before I decided that the added risk to me, given my age, comorbidies, etc was statistically pretty small given the risks I have anyway, plus the risks (and unpleasantness) of ADT itself. However, I'm getting most of the ADT symptoms anyway. Who knows about the risks.

Note that I have severe hypogonadism. The trial allows people with normal T, so they probably have even higher tisk.

Adding to my response... the purpose of the trial is to find out if and under what conditions ADT can safely be reduced or done away with, in high risk PC cases (i.e. Grade Group 5).

As for AI - I used Grok, plus looked at some of the clinical trials and other papers it found.